PMCF Study on the Safety of Linovera Emulsion for the Prevention of Cat-1 Pressure Ulcers, Vascular and DFU

Inclusion Criteria: * Age ≥ 18 years * Signed informed consent * Patients with the possibility to participate during up 6 month follow-up. * At least one of these criteria: * Patients with medium, high or very high risk of amputation due to a vascular or diabetic foot illness. * Patients with medium, high or very high risk of developing a pressure ulcer due to any neuropathic foot pathology * Patients with medium, high or very high risk of developing a pressure ulcer following Braden Scale. Exclusion Criteria: * Age \< 18 years * Known allergies and/or hypersensitivity to any component of Linovera® Emulsion. * Any medical or psychological disorder that, in the investigator's opinion, may interfere with the patient's ability to give informed consent and comply with the study procedures. * Patients in the terminal stage or receiving chemotherapy. * Patients with more than 3 active pressure ulcers.